Tag:
drug delivery deals
Latest Headlines
Latest Headlines
With Éclat, Flamel gains regulatory brains, drug delivery pipeline
French drug delivery company Flamel Technologies ( $FLML ) is snatching up St. Louis-based Éclat Pharmaceuticals to access its specialty pharmaceutical and regulatory muscle for a planned expansion in the U.S. and elsewhere.
June deals a snapshot of drug-delivery trends
Here's a drug-delivery clip-'n'-saver from PMLiVE, a website run by pharma-industry publishers PMGroup. It's a rundown of all the major drug-delivery deals in June 2011, but it also serves as a clear
Aegis, Albany Medical College use pregnancy-produced protein against breast cancer
Aegis Therapeutics, a San Diego-based drug-delivery company, is using its Intravail formulation technology to deliver a potential new breast cancer drug in a partnership with Albany Medical College
OncoSec, cancer drug delivery firm, taking form
A new drug developer is forming to commercialize a way to boost the uptake cancer treatments in tumor cells. OncoSec Medical has completed a series of deals over the past month or so to propel its
Depomed licenses Acuform to Boehringer
Depomed says Boehringer Ingelheim licensed worldwide rights to Depomed's Acuform gastric retentive drug delivery technology to develop and commercialize extended release metformin for type 2
Zambon unit licenses drug-delivery microdevice from UCSF
Italian pharmaceutical dollars are now behind a microdevice engineered to carry medicines directly to the gut. Zcube, a venture arm of the Bresso, Italy-based pharma Zambon, has inked a deal with the
